The synergistic effect of acupuncture and computer-based cognitive training on post-stroke cognitive dysfunction: a study protocol for a randomized controlled trial of 2?×- factorial design

详细信息    查看全文

• 作者：Shanli Yang ; Haicheng Ye ; Jia Huang ; Jing Tao…
• 关键词：Acupuncture ; Computer ; based cognitive training ; Stroke ; Cognitive dysfunction
• 刊名：BMC Complementary and Alternative Medicine
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：749 KB
• 参考文献：1. Minino, AM, Murphy, SL, Xu, J, Kochanek, KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59: pp. 1-126
  2. Tarraga, L, Boada, M, Modinos, G, Espinosa, A, Diego, S, Morera, A, Guitart, M, Balcells, J, Lopez, OL, Becker, JT (2006) A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 77: pp. 1116-1121 CrossRef
  3. Franceschi, C (2010) So as to avoid any misunderstanding about Cure Conservatrice et Hemodynamique de l’Insuffisance Veineuse en Ambulatoire (CHIVA). Phlebology 25: pp. 212-213 CrossRef
  4. Haring, HP (2002) Cognitive impairment after stroke. Curr Opin Neurol 15: pp. 79-84
  5. Mok, VC, Wong, A, Lam, WW, Fan, YH, Tang, WK, Kwok, T, Hui, AC, Wong, KS (2004) Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry 75: pp. 560-566 CrossRef
  6. Mok, V, Chang, C, Wong, A, Lam, WW, Richards, PS, Wong, KT, Wong, KS (2005) Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease. J Neuroimaging 15: pp. 129-137 CrossRef
  7. Alvarez-Sabin, J, Roman, GC (2011) Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke 42: pp. S40-S43 CrossRef
  8. Tatemichi, TK, Desmond, DW, Stern, Y, Paik, M, Sano, M, Bagiella, E (1994) Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 57: pp. 202-207 CrossRef
  9. Desmond, DW, Moroney, JT, Paik, MC, Sano, M, Mohr, JP, Aboumatar, S, Tseng, CL, Chan, S, Williams, JB, Remien, RH (2000) Frequency and clinical determinants of dementia after ischemic stroke. Neurology 54: pp. 1124-1131 CrossRef
  10. Hachinski, V, Munoz, D (2000) Vascular factors in cognitive impairment–where are we now?. Ann N Y Acad Sci 903: pp. 1-5 CrossRef
  11. Pendlebury, ST, Rothwell, PM (2009) Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8: pp. 1006-1018 CrossRef
  12. Stingele, R, Berger, J, Alfke, K, Eckstein, HH, Fraedrich, G, Allenberg, J, Hartmann, M, Ringleb, PA, Fiehler, J, Bruckmann, H, Hennerici, M, Jansen, O, Klein, G, Kunze, A, Marx, P, Niederkorn, K, Schmiedt, W, Solymosi, L, Zeumer, H, Hacke, W (2008) Clinical and angiographic risk factors for stroke and death within 30?days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol 7: pp. 216-222 CrossRef
  13. Shim, H (2014) Vascular cognitive impairment and post-stroke cognitive deficits. Curr Neurol Neurosci Rep 14: pp. 418 CrossRef
  14. Farooq, MU, Gorelick, PB (2013) Vascular cognitive impairment. Curr Atheroscler Rep 15: pp. 330 CrossRef
  15. Jansen, G, Lundeberg, T, Kjartansson, J, Samuelson, UE (1989) Acupuncture and sensory neuropeptides increase cutaneous blood flow in rats. Neurosci Lett 97: pp. 305-309 CrossRef
  16. Johansson, K, Lindgren, I, Widner, H, Wiklund, I, Johansson, BB (1993) Can sensory stimulation improve the functional outcome in stroke patients?. Neurology 43: pp. 2189-2192 CrossRef
  17. Hu, HH, Chung,
• 刊物主题：Complementary & Alternative Medicine; Internal Medicine; Chiropractic Medicine;
• 出版者：BioMed Central
• ISSN：1472-6882

文摘

Background Stroke is one of the most common causes of cognitive impairment. Up to 75% of stroke survivors may be considered to have cognitive impairment, which severely limit individual autonomy for successful reintegration into family, work and social life. The clinical efficacy of acupuncture with Baihui (DU20) and Shenting (DU24) in stroke and post-stroke cognitive impairment has been previously demonstrated. Computer-assisted cognitive training is part of conventional cognitive rehabilitation and has also shown to be effective in improvement of cognitive function of affected patients. However, the cognitive impairment after stroke is so complexity that one single treatment cannot resolve effectively. Besides, the effects of acupuncture and RehaCom cognitive training have not been systematically compared, nor has the possibility of a synergistic effect of combination of the two therapeutic modalities been evaluated. Our primary aim of this trial is to evaluate the synergistic effect of acupuncture and RehaCom cognitive training on cognitive dysfunction after stroke. Method/Design A randomized controlled trial of 2?×- factorial design will be conducted in the Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine. A total of 240 patients with cognitive dysfunction after stroke who meet the eligibility criteria will be recruited and randomized into RehaCom training group, acupuncture group, a combination of both or control group in a 1:1:1:1 ratio. All patients will receive conventional treatment. The interventions will last for 12?weeks (30?min per day, Monday to Friday every week). Evaluations will be conducted by blinded assessors at baseline and again at 4, 8 and 12?weeks. Outcome measurements include mini–mental state examination (MMSE), Montreal cognitive assessments (MoCA), functional independence measure scale (FIM) and adverse events. Discussion The results of this trial are expected to clarify the synergistic effect of acupuncture and RehaCom cognitive training on cognitive dysfunction after stroke. Furthermore, to confirm whether combined or alone of acupuncture and RehaCom cognitive training, is more effective than conventional treatment in the management of post-stroke cognitive dysfunction. Trial registration Chinese Clinical Trial Registry: ChiCTR-TRC-13003704. Registration date: 4 September, 2013.